Euromedis Group's half-year results are expected to rise in 2026.

Euromedis Groupe reports strong half-year results for the first half of 2026. Net sales reached €22.8 million, an increase of 11.6% compared to the same period in 2025. This growth is supported by an increase in export and intra-community sales.

Gross profit amounted to €7.8 million, representing 34% of revenue, compared to 27.9% the previous year. Net profit was €3.9 million, including the positive impact of the property sale.

For the second half of the year, Euromedis is continuing its optimization efforts despite an uncertain international context and nevertheless expects a decline in operating profitability.